Login / Signup

Severe Delayed-Onset Neutropenia Induced by Ocrelizumab.

Jonathan Baird-GunningJames YunWilliam StevensonKarl Ng
Published in: The Neurohospitalist (2020)
Late-onset neutropenia is a rare complication of ocrelizumab. Patients should be counseled to present for urgent evaluation if they develop fever.
Keyphrases
  • late onset
  • early onset
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • chemotherapy induced
  • patient reported